The global market for Oral Thin-film Drug Delivery was valued at US$ 6993 million in the year 2024 and is projected to reach a revised size of US$ 9988 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
The Thin-film Drug Delivery market is driven by the growing need for convenient and patient-friendly drug delivery solutions. Thin-film drug delivery systems offer a unique way to administer medications through dissolvable or wearable films, providing benefits such as ease of use, discreetness, and potential for controlled release. The rise in chronic diseases and the need for personalized medicine contribute to market growth, as patients and healthcare providers seek innovative alternatives to traditional oral medications or injections. Moreover, advancements in thin-film technology and formulations align with improved drug stability, bioavailability, and patient adherence, fostering market adoption. However, the market also faces challenges, including the complexity of formulating drugs in thin-film formats and ensuring consistent drug release profiles. Additionally, addressing concerns related to regulatory approvals, scalability of manufacturing processes, and intellectual property can pose obstacles for manufacturers. To succeed, companies must focus on formulation expertise, rigorous quality control, and addressing the challenges to provide patients with reliable and effective thin-film drug delivery systems that enhance medication compliance and improve patient outcomes.
This report aims to provide a comprehensive presentation of the global market for Oral Thin-film Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Thin-film Drug Delivery.
The Oral Thin-film Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Thin-film Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Thin-film Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
GSK
LTS
J&J
Indivior
Pfizer
Church & Dwight
tesa Labtec
Tapemark
Prestige
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Segment by Type
OTC
Rx
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Thin-film Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Oral Thin-film Drug Delivery 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 OTC
1.2.3 Rx
1.3 麻豆原创 by Application
1.3.1 Global Oral Thin-film Drug Delivery 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Thin-film Drug Delivery 麻豆原创 Perspective (2020-2031)
2.2 Global Oral Thin-film Drug Delivery Growth Trends by Region
2.2.1 Global Oral Thin-film Drug Delivery 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral Thin-film Drug Delivery Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Oral Thin-film Drug Delivery Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Oral Thin-film Drug Delivery 麻豆原创 Dynamics
2.3.1 Oral Thin-film Drug Delivery Industry Trends
2.3.2 Oral Thin-film Drug Delivery 麻豆原创 Drivers
2.3.3 Oral Thin-film Drug Delivery 麻豆原创 Challenges
2.3.4 Oral Thin-film Drug Delivery 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Thin-film Drug Delivery Players by Revenue
3.1.1 Global Top Oral Thin-film Drug Delivery Players by Revenue (2020-2025)
3.1.2 Global Oral Thin-film Drug Delivery Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Oral Thin-film Drug Delivery 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral Thin-film Drug Delivery Revenue
3.4 Global Oral Thin-film Drug Delivery 麻豆原创 Concentration Ratio
3.4.1 Global Oral Thin-film Drug Delivery 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Thin-film Drug Delivery Revenue in 2024
3.5 Global Key Players of Oral Thin-film Drug Delivery Head office and Area Served
3.6 Global Key Players of Oral Thin-film Drug Delivery, Product and Application
3.7 Global Key Players of Oral Thin-film Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Thin-film Drug Delivery Breakdown Data by Type
4.1 Global Oral Thin-film Drug Delivery Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Oral Thin-film Drug Delivery Forecasted 麻豆原创 Size by Type (2026-2031)
5 Oral Thin-film Drug Delivery Breakdown Data by Application
5.1 Global Oral Thin-film Drug Delivery Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Oral Thin-film Drug Delivery Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Oral Thin-film Drug Delivery 麻豆原创 Size (2020-2031)
6.2 North America Oral Thin-film Drug Delivery 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2020-2025)
6.4 North America Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Thin-film Drug Delivery 麻豆原创 Size (2020-2031)
7.2 Europe Oral Thin-film Drug Delivery 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2020-2025)
7.4 Europe Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Thin-film Drug Delivery 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Oral Thin-film Drug Delivery 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral Thin-film Drug Delivery 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Oral Thin-film Drug Delivery 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Thin-film Drug Delivery 麻豆原创 Size (2020-2031)
9.2 Latin America Oral Thin-film Drug Delivery 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Thin-film Drug Delivery 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Oral Thin-film Drug Delivery 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Oral Thin-film Drug Delivery 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Oral Thin-film Drug Delivery Introduction
11.1.4 GSK Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.1.5 GSK Recent Development
11.2 LTS
11.2.1 LTS Company Details
11.2.2 LTS Business Overview
11.2.3 LTS Oral Thin-film Drug Delivery Introduction
11.2.4 LTS Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.2.5 LTS Recent Development
11.3 J&J
11.3.1 J&J Company Details
11.3.2 J&J Business Overview
11.3.3 J&J Oral Thin-film Drug Delivery Introduction
11.3.4 J&J Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.3.5 J&J Recent Development
11.4 Indivior
11.4.1 Indivior Company Details
11.4.2 Indivior Business Overview
11.4.3 Indivior Oral Thin-film Drug Delivery Introduction
11.4.4 Indivior Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.4.5 Indivior Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Oral Thin-film Drug Delivery Introduction
11.5.4 Pfizer Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Church & Dwight
11.6.1 Church & Dwight Company Details
11.6.2 Church & Dwight Business Overview
11.6.3 Church & Dwight Oral Thin-film Drug Delivery Introduction
11.6.4 Church & Dwight Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.6.5 Church & Dwight Recent Development
11.7 tesa Labtec
11.7.1 tesa Labtec Company Details
11.7.2 tesa Labtec Business Overview
11.7.3 tesa Labtec Oral Thin-film Drug Delivery Introduction
11.7.4 tesa Labtec Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.7.5 tesa Labtec Recent Development
11.8 Tapemark
11.8.1 Tapemark Company Details
11.8.2 Tapemark Business Overview
11.8.3 Tapemark Oral Thin-film Drug Delivery Introduction
11.8.4 Tapemark Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.8.5 Tapemark Recent Development
11.9 Prestige
11.9.1 Prestige Company Details
11.9.2 Prestige Business Overview
11.9.3 Prestige Oral Thin-film Drug Delivery Introduction
11.9.4 Prestige Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.9.5 Prestige Recent Development
11.10 MonoSol
11.10.1 MonoSol Company Details
11.10.2 MonoSol Business Overview
11.10.3 MonoSol Oral Thin-film Drug Delivery Introduction
11.10.4 MonoSol Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.10.5 MonoSol Recent Development
11.11 BioDelivery
11.11.1 BioDelivery Company Details
11.11.2 BioDelivery Business Overview
11.11.3 BioDelivery Oral Thin-film Drug Delivery Introduction
11.11.4 BioDelivery Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.11.5 BioDelivery Recent Development
11.12 Arx
11.12.1 Arx Company Details
11.12.2 Arx Business Overview
11.12.3 Arx Oral Thin-film Drug Delivery Introduction
11.12.4 Arx Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.12.5 Arx Recent Development
11.13 ZIM
11.13.1 ZIM Company Details
11.13.2 ZIM Business Overview
11.13.3 ZIM Oral Thin-film Drug Delivery Introduction
11.13.4 ZIM Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.13.5 ZIM Recent Development
11.14 NAL Pharma
11.14.1 NAL Pharma Company Details
11.14.2 NAL Pharma Business Overview
11.14.3 NAL Pharma Oral Thin-film Drug Delivery Introduction
11.14.4 NAL Pharma Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.14.5 NAL Pharma Recent Development
11.15 AdhexPharma
11.15.1 AdhexPharma Company Details
11.15.2 AdhexPharma Business Overview
11.15.3 AdhexPharma Oral Thin-film Drug Delivery Introduction
11.15.4 AdhexPharma Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.15.5 AdhexPharma Recent Development
11.16 Aavishkar
11.16.1 Aavishkar Company Details
11.16.2 Aavishkar Business Overview
11.16.3 Aavishkar Oral Thin-film Drug Delivery Introduction
11.16.4 Aavishkar Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.16.5 Aavishkar Recent Development
11.17 IntelGenx Corp
11.17.1 IntelGenx Corp Company Details
11.17.2 IntelGenx Corp Business Overview
11.17.3 IntelGenx Corp Oral Thin-film Drug Delivery Introduction
11.17.4 IntelGenx Corp Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.17.5 IntelGenx Corp Recent Development
11.18 APR
11.18.1 APR Company Details
11.18.2 APR Business Overview
11.18.3 APR Oral Thin-film Drug Delivery Introduction
11.18.4 APR Revenue in Oral Thin-film Drug Delivery Business (2020-2025)
11.18.5 APR Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
GSK
LTS
J&J
Indivior
Pfizer
Church & Dwight
tesa Labtec
Tapemark
Prestige
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
听
听
*If Applicable.